Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis.
Information processing speed in multiple sclerosis: Past, present, and future.
Pediatric Optic Neuritis Prospective Outcomes Study.
Sunshine, Sea, and Season of Birth: MS Incidence in Wales.
Difficulties in adjustment to multiple sclerosis: vulnerability and unpredictability of illness in the foreground.
Static posturography across the EDSS scale in people with multiple sclerosis: a cross sectional study.
Astrocyte tissue factor controls CNS hemostasis and autoimmune inflammation.
All relapsing multiple sclerosis patients should be managed at a specialist clinic - YES.
Mucocele After Orbital Fracture Repair Masquerading as Optic Neuritis.
Systematic Review and Critique of Health Economic Models on Relapsing-Remitting Multiple Sclerosis in the UK.
Cost-Effectiveness of Subcutaneous Interferon Beta-1A in a Sub-Population of Multiple Sclerosis Patients (Kurtzke Expanded Disability Status Scale [EDSS]: >3.5-5.0).
The Rao's Brief Repeatable Battery in the study of cognition in different multiple sclerosis phenotypes: application of normative data in a Serbian population.
A fatal mycotic sepsis after retrograde intrarenal surgery: a case report and literature review.
Using a Panel Survey to Identify Predictors of Disease-Modifying Drug Adherence in Patients with Multiple Sclerosis.
Comparison of a Markov Cohort Model and a Discrete-Event Simulation for Economic Analyses of Treatments for Multiple Sclerosis.
Working Ability and Monetarily Valued Productivity of Patients with Multiple Sclerosis Treated with Natalizumab.
A surface-based technique for mapping homotopic interhemispheric connectivity: Development, characterization, and clinical application.
Optic neuritis as a presenting symptom of Mycoplasma pneumoniae infection.
ERβ in CD4+ T Cells Is Crucial for Ligand-Mediated Suppression of Central Nervous System Autoimmunity.
Tbet or Continued RORγt Expression Is Not Required for Th17-Associated Immunopathology.
Elevated CSF neurofilament proteins predict brain atrophy: A 15-year follow-up study.
An Economic Evaluation of Subcutaneous and Intramuscular Interferon Beta-1a in Multiple Sclerosis Using a Direct Head-To-Head Study.
Expected Value of Partial Perfect Information for the Disability Progression Efficacy of Teriflunomide and Fingolimod in the Treatment of Relapsing-Remitting Multiple Sclerosis.
Effect of Alfacalcidol on multiple sclerosis-related fatigue: A randomized, double-blind placebo-controlled study.
The Cost Burden of Switching Patients with Relapsing-Remitting Multiple Sclerosis from Glatiramer Acetate To Newly-Approved Disease Modifying Therapies.
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »